{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:20:51Z","timestamp":1793740851103,"version":"4.6.1"},"reference-count":120,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1053\/j.seminhematol.2017.04.004","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T18:16:48Z","timestamp":1491589008000},"page":"105-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia"],"prefix":"10.1053","volume":"54","author":[{"given":"Sharon A.","family":"Savage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.seminhematol.2017.04.004_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2010.08212.x","article-title":"Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study","volume":"150","author":"Alter","year":"2010","journal-title":"Br J Haematol"},{"issue":"128","key":"10.1053\/j.seminhematol.2017.04.004_bib2","first-page":"22","article-title":"Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after 15 years of follow-up","volume":"334","author":"Alter BP.","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2017.04.004_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40246-015-0054-y","article-title":"Update of the human and mouse Fanconi anemia genes","volume":"24","author":"Dong","year":"2015","journal-title":"Hum Genom"},{"issue":"9","key":"10.1053\/j.seminhematol.2017.04.004_bib4","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1172\/JCI88010","article-title":"Biallelic inactivation of REV7 is associated with Fanconi anemia","volume":"126","author":"Bluteau","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gde.2015.07.002","article-title":"Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics","volume":"33","author":"Bogliolo","year":"2015","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"10.1053\/j.seminhematol.2017.04.004_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/blood-2004-08-3033","article-title":"Hypoxia-reoxygenation induces premature senescence in FA bone marrow hematopoietic cells","volume":"106","author":"Zhang","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2017.04.004_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.molmed.2013.07.008","article-title":"Mitochondrial respiratory complex I defects in Fanconi anemia","volume":"19","author":"Cappelli","year":"2013","journal-title":"Trends Mol Med"},{"issue":"7417","key":"10.1053\/j.seminhematol.2017.04.004_bib8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nature11368","article-title":"Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function","volume":"489","author":"Garaycoechea","year":"2012","journal-title":"Nature"},{"issue":"6","key":"10.1053\/j.seminhematol.2017.04.004_bib9","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood-2003-01-0114","article-title":"TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro","volume":"102","author":"Dufour","year":"2003","journal-title":"Blood"},{"issue":"26","key":"10.1053\/j.seminhematol.2017.04.004_bib10","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1182\/blood-2009-05-222414","article-title":"TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells","volume":"114","author":"Vanderwerf","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2017.04.004_bib11","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/ajmg.a.37637","article-title":"Thinking of VACTERL-H? Rule out Fanconi anemia according to PHENOS","volume":"170","author":"Alter","year":"2016","journal-title":"Am J Med Genet"},{"issue":"3-4","key":"10.1053\/j.seminhematol.2017.04.004_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.beha.2014.10.002","article-title":"Fanconi anemia and the development of leukemia","volume":"27","author":"Alter","year":"2014","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2017.04.004_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ajmg.a.37461","article-title":"Novel FANCI mutations in Fanconi anemia with VACTERL association","volume":"170A","author":"Savage","year":"2016","journal-title":"Am J Med Genet"},{"issue":"7","key":"10.1053\/j.seminhematol.2017.04.004_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ajh.24373","volume":"91","author":"Svahn","year":"2016","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1053\/j.seminhematol.2017.04.004_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103270","article-title":"Improving diagnostic precision, care and syndrome definitions using comprehensive next-generation sequencing for the inherited bone marrow failure syndromes","volume":"52","author":"Ghemlas","year":"2015","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1399-3046.2005.00440.x","article-title":"Fanconi\u05f3s anemia, transplantation, and cancer","volume":"7","author":"Alter","year":"2005","journal-title":"Pediatr Transplant Suppl"},{"issue":"1","key":"10.1053\/j.seminhematol.2017.04.004_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40348-014-0009-8","article-title":"Fanconi anemia: young patients at high risk for squamous cell carcinoma","volume":"1","author":"Velleuer","year":"2014","journal-title":"Mol Cell Pediatr"},{"issue":"1","key":"10.1053\/j.seminhematol.2017.04.004_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1182\/blood-2004-04-1652","article-title":"Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants","volume":"105","author":"Rosenberg","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2017.04.004_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/sj.leu.2404468","article-title":"A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia","volume":"21","author":"Borriello","year":"2007","journal-title":"Leukemia"},{"issue":"24","key":"10.1053\/j.seminhematol.2017.04.004_bib20","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1182\/blood-2016-01-583625","article-title":"How I treat MDS and AML in Fanconi anemia","volume":"127","author":"Peffault de Latour","year":"2016","journal-title":"Blood"},{"issue":"26","key":"10.1053\/j.seminhematol.2017.04.004_bib21","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2013-01-479733","article-title":"Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience","volume":"122","author":"Peffault de Latour","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2017.04.004_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood-2014-10-605113","article-title":"HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabine","volume":"125","author":"Benajiba","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib23","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.bbmt.2007.08.004","article-title":"HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg\/kg of cyclophosphamide","volume":"13","author":"Bonfim","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib24","unstructured":"Bonfim C, Ribeiro LL, Nichele S, et al. Haplo identical transplantation with post-transplantation cyclophosphamide (PT-CY) in the treatment of patients with Fanconi Anemia: experience of Curitiba, Abstract book of the 28th Annual FARF Symposium, Sept 2016, Bellevue, WA, p 36."},{"issue":"24","key":"10.1053\/j.seminhematol.2017.04.004_bib25","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood-2015-02-626002","article-title":"Alternative donor hematopoietic cell transplantation for Fanconi anemia","volume":"125","author":"MacMillan","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2017.04.004_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/08880018.2015.1129567","article-title":"Androgen therapy in Fanconi anemia: a retrospective analysis of 30 years in Germany","volume":"33","author":"Paustian","year":"2016","journal-title":"Pediatr Hematol Oncol"},{"issue":"6","key":"10.1053\/j.seminhematol.2017.04.004_bib27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.15252\/emmm.201303374","article-title":"Targeted gene therapy and cell reprogramming in Fanconi anemia","volume":"6","author":"Rio","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2017.04.004_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2014.170","article-title":"Clinical utility gene card for: Dyskeratosis congenital\u2014update 2015","volume":"23","author":"Dokal","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1053\/j.seminhematol.2017.04.004_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1586\/ehm.13.23","article-title":"Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders","volume":"6","author":"Ballew","year":"2013","journal-title":"Expert Rev Hematol"},{"issue":"8","key":"10.1053\/j.seminhematol.2017.04.004_bib30","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/15476286.2015.1094596","article-title":"The molecular genetics of the telomere biology disorders","volume":"13","author":"Bertuch","year":"2016","journal-title":"RNA Biol"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib31","series-title":"Dyskeratosis congenita. SourceGeneReviews","author":"Savage","year":"2009"},{"issue":"1","key":"10.1053\/j.seminhematol.2017.04.004_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng0598-32","article-title":"X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions","volume":"19","author":"Heiss","year":"1998","journal-title":"Nat Genet"},{"issue":"6761","key":"10.1053\/j.seminhematol.2017.04.004_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/990141","article-title":"A telomerase component is defective in the human disease dyskeratosis congenita","volume":"402","author":"Mitchell","year":"1999","journal-title":"Nature"},{"issue":"3","key":"10.1053\/j.seminhematol.2017.04.004_bib34","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood-2003-01-0335","article-title":"Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome","volume":"102","author":"Yamaguchi","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2017.04.004_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/ng1346","article-title":"Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC","volume":"36","author":"Vulliamy","year":"2004","journal-title":"Nat Genet"},{"issue":"3","key":"10.1053\/j.seminhematol.2017.04.004_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bcmd.2004.12.008","article-title":"Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure","volume":"34","author":"Vulliamy","year":"2005","journal-title":"Blood Cells Mol Dis"},{"issue":"14","key":"10.1053\/j.seminhematol.2017.04.004_bib37","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa042980","article-title":"Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia","volume":"352","author":"Yamaguchi","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2017.04.004_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajhg.2007.10.004","article-title":"TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita","volume":"82","author":"Savage","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"18","key":"10.1053\/j.seminhematol.2017.04.004_bib39","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1182\/blood-2014-08-596445","article-title":"Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1","volume":"124","author":"Guo","year":"2014","journal-title":"Blood"},{"issue":"19","key":"10.1053\/j.seminhematol.2017.04.004_bib40","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1101\/gad.248567.114","article-title":"Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1","volume":"28","author":"Kocak","year":"2014","journal-title":"Genes Dev"},{"issue":"5","key":"10.1053\/j.seminhematol.2017.04.004_bib41","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ng.3278","article-title":"Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening","volume":"47","author":"Stuart","year":"2015","journal-title":"Nat Genet"},{"issue":"8","key":"10.1053\/j.seminhematol.2017.04.004_bib42","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1084\/jem.20151618","article-title":"Mutations in STN1 cause Coats plus syndrome and are associated with genomic and telomere defects","volume":"213","author":"Simon","year":"2016","journal-title":"J Exp Med"},{"issue":"7","key":"10.1053\/j.seminhematol.2017.04.004_bib43","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1101\/gad.276873.115","article-title":"A POT1 mutation implicates defective telomere end fill-in and telomere truncations in Coats plus","volume":"30","author":"Takai","year":"2016","journal-title":"Genes Dev"},{"issue":"4","key":"10.1053\/j.seminhematol.2017.04.004_bib44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00439-013-1265-8","article-title":"Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in dyskeratosis congenita","volume":"132","author":"Ballew","year":"2013","journal-title":"Hum Genet"},{"issue":"16","key":"10.1053\/j.seminhematol.2017.04.004_bib45","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1093\/hmg\/ddt178","article-title":"Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and genome instability","volume":"22","author":"Le Guen","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1053\/j.seminhematol.2017.04.004_bib46","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ajhg.2013.02.001","article-title":"Constitutional mutations in RTEL1 cause severe dyskeratosis congenita","volume":"92","author":"Walne","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1053\/j.seminhematol.2017.04.004_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1101\/gad.2006411","article-title":"Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita","volume":"25","author":"Zhong","year":"2011","journal-title":"Genes Dev"},{"issue":"3","key":"10.1053\/j.seminhematol.2017.04.004_bib48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng.1084","article-title":"Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus","volume":"44","author":"Anderson","year":"2012","journal-title":"Nat Genet"},{"issue":"2","key":"10.1053\/j.seminhematol.2017.04.004_bib49","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/pbc.24193","article-title":"CTC1 Mutations in a patient with dyskeratosis congenita","volume":"59","author":"Keller","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1053\/j.seminhematol.2017.04.004_bib50","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ajhg.2012.02.002","article-title":"Mutations in CTC1, encoding the CTS telomere maintenance complex component 1, cause cerebroretinal microangiopathy with calcifications and cysts","volume":"90","author":"Polvi","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1053\/j.seminhematol.2017.04.004_bib51","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1172\/JCI78963","article-title":"Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita","volume":"125","author":"Tummala","year":"2015","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.seminhematol.2017.04.004_bib52","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","article-title":"Dyskeratosis congenita in all its forms","volume":"110","author":"Dokal","year":"2000","journal-title":"Br J Haematol"},{"issue":"26","key":"10.1053\/j.seminhematol.2017.04.004_bib53","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1182\/blood-2008-12-192880","article-title":"Cancer in dyskeratosis congenita","volume":"113","author":"Alter","year":"2009","journal-title":"Blood"},{"issue":"44","key":"10.1053\/j.seminhematol.2017.04.004_bib54","doi-asserted-by":"crossref","first-page":"15960","DOI":"10.1073\/pnas.0508124102","article-title":"Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita","volume":"102","author":"Armanios","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1053\/j.seminhematol.2017.04.004_bib55","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2017.04.004_bib56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2011.055269","article-title":"Telomere length is associated with disease severity and declines with age in dyskeratosis congenita","volume":"97","author":"Alter","year":"2012","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib57","series-title":"Dyskeratosis congenita and telomere biology disorders: diagnosis and management guidelines","year":"2015"},{"issue":"1","key":"10.1053\/j.seminhematol.2017.04.004_bib58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/bmt.2010.65","article-title":"Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita","volume":"46","author":"Dietz","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1053\/j.seminhematol.2017.04.004_bib59","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbmt.2013.05.021","article-title":"Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita","volume":"19","author":"Gadalla","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1053\/j.seminhematol.2017.04.004_bib60","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2016.03.001","article-title":"Survival after hematopoietic stem cell transplant in patients with dyskeratosis congenita: systematic review of the literature","volume":"22","author":"Barbaro","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"10.1053\/j.seminhematol.2017.04.004_bib61","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","article-title":"Danazol treatment for telomere diseases","volume":"374","author":"Townsley","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2017.04.004_bib62","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/bjh.12748","article-title":"Response to androgen therapy in patients with dyskeratosis congenita","volume":"165","author":"Khincha","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib63","unstructured":"Myers K. Shwachman-Diamond syndrome, in Pagon RA, et al, editors. Gene reviews(R). Seattle (WA): University of Washington, Seattle; 1993-2017."},{"issue":"1","key":"10.1053\/j.seminhematol.2017.04.004_bib64","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng1062","article-title":"Mutations in SBDS are associated with Shwachman-Diamond syndrome","volume":"33","author":"Boocock","year":"2003","journal-title":"Nat Genet"},{"issue":"9","key":"10.1053\/j.seminhematol.2017.04.004_bib65","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1093\/nar\/gkw005","article-title":"Shwachman-Bodian-Diamond syndrome (SBDS) protein deficiency impairs translation re-initiation from C\/EBPalpha and C\/EBPbeta mRNAs","volume":"44","author":"In","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1053\/j.seminhematol.2017.04.004_bib66","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jpeds.2013.11.039","article-title":"Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry","volume":"164","author":"Myers","year":"2014","journal-title":"J Pediatr"},{"issue":"2","key":"10.1053\/j.seminhematol.2017.04.004_bib67","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2141.1996.d01-1788.x","article-title":"Haematological abnormalities in Shwachman-Diamond syndrome","volume":"94","author":"Smith","year":"1996","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1053\/j.seminhematol.2017.04.004_bib68","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1182\/blood-2005-11-4370","article-title":"The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy","volume":"107","author":"Rosenberg","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2017.04.004_bib69","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3324\/haematol.2011.057489","article-title":"Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome","volume":"97","author":"Donadieu","year":"2012","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.2011.06349.x","article-title":"Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome","volume":"1242","author":"Dror","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1053\/j.seminhematol.2017.04.004_bib71","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hoc.2009.01.007","article-title":"Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment","volume":"23","author":"Burroughs","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib72","series-title":"Diamond-Blackfan anemia. GeneReviews","author":"Clinton","year":"2009"},{"issue":"3","key":"10.1053\/j.seminhematol.2017.04.004_bib73","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1586\/17474086.2014.897923","article-title":"Diamond Blackfan anemia: a model for the translational approach to understanding human disease","volume":"7","author":"Vlachos","year":"2014","journal-title":"Expert Rev Hematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2017.04.004_bib74","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/5951","article-title":"The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia","volume":"21","author":"Draptchinskaia","year":"1999","journal-title":"Nat Genet"},{"issue":"7","key":"10.1053\/j.seminhematol.2017.04.004_bib75","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1172\/JCI63597","article-title":"Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia","volume":"122","author":"Sankaran","year":"2012","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1053\/j.seminhematol.2017.04.004_bib76","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/ajmg.a.36633","article-title":"Diamond-Blackfan anemia with mandibulofacial dystostosis is heterogeneous, including the novel DBA genes TSR2 and RPS28","volume":"164A","author":"Gripp","year":"2014","journal-title":"Am J Med Genet A"},{"issue":"19","key":"10.1053\/j.seminhematol.2017.04.004_bib77","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2010-02-251090","article-title":"How I treat Diamond-Blackfan anemia","volume":"116","author":"Vlachos","year":"2010","journal-title":"Blood"},{"issue":"24","key":"10.1053\/j.seminhematol.2017.04.004_bib78","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJM198312153092404","article-title":"Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia","volume":"309","author":"Glader","year":"1983","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2017.04.004_bib79","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/bjh.12167","article-title":"Erythrocyte adenosine deaminase: diagnostic value for Diamond-Blackfan anaemia","volume":"160","author":"Fargo","year":"2013","journal-title":"Br J Haematol"},{"issue":"16","key":"10.1053\/j.seminhematol.2017.04.004_bib80","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood-2011-08-375972","article-title":"Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry","volume":"119","author":"Vlachos","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib81","article-title":"Cancer risk in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Oral session: 508. Bone Marrow Failure: Long-Term Cancer Risks, New Molecular Pathways, and Models of DBA and SDS","author":"Vlachos","year":"2016","journal-title":"ASH Congress"},{"issue":"11","key":"10.1053\/j.seminhematol.2017.04.004_bib82","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ajh.21541","article-title":"Severe iron overload in Blackfan-Diamond anemia: a case-control study","volume":"84","author":"Roggero","year":"2009","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1053\/j.seminhematol.2017.04.004_bib83","first-page":"895","article-title":"The role of the DNA damage response in zebrafish and cellular models of Diamond Blackfan anemia","volume":"7","author":"Danilova","year":"2014","journal-title":"Dis Model Mech"},{"issue":"4","key":"10.1053\/j.seminhematol.2017.04.004_bib84","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/bjh.13069","article-title":"L-Leucine improves the anaemia in models of Diamond Blackfan anaemia and the 5q- syndrome in a TP53-independent way","volume":"167","author":"Narla","year":"2014","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1053\/j.seminhematol.2017.04.004_bib85","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbmt.2005.05.005","article-title":"Bone marrow transplantation for diamond-blackfan anemia","volume":"11","author":"Roy","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib86","series-title":"Nathan and Oshi\u2019s hematology of infancy and childhood","first-page":"923","article-title":"The phagocyte system and disorders of granulopoiesis and granulocyte function","author":"Dinauer","year":"2003"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib87","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.seminhematol.2006.04.004","article-title":"Severe congenital neutropenia","volume":"43","author":"Welte","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2012.11.003","article-title":"Epidemiology of congenital neutropenia","volume":"27","author":"Donadieu","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1053\/j.seminhematol.2017.04.004_bib89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MOH.0000000000000105","article-title":"The diversity of mutations and clinical outcomes for ELANE-associated neutropenia","volume":"22","author":"Makaryan","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib90","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ng1940","article-title":"HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)","volume":"39","author":"Klein","year":"2007","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib91","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2141.2009.07888.x","article-title":"Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia","volume":"147","author":"Xia","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib92","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ng1170","article-title":"Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2","volume":"34","author":"Person","year":"2003","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib93","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa0805051","article-title":"A syndrome with congenital neutropenia and mutations in G6PC3","volume":"360","author":"Boztug","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib94","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/85886","article-title":"Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia","volume":"27","author":"Devriendt","year":"2001","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib95","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/humu.22563","article-title":"TCIRG1-associated congenital neutropenia","volume":"35","author":"Makaryan","year":"2014","journal-title":"Hum Mutat"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib96","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/ng.3069","article-title":"JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia","volume":"46","author":"Boztug","year":"2014","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2016.02.008","article-title":"Novel CLPB mutation in a patient with 3-methylglutaconic aciduria causing severe neurological involvement and congenital neutropenia","volume":"165","author":"Kiykim","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib98","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2006-11-057299","article-title":"Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis","volume":"110","author":"Grenda","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib99","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-6-26","article-title":"Congenital neutropenia: diagnosis, molecular bases and patient management","volume":"6","author":"Donadieu","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib100","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1182\/blood-2013-11-535419","article-title":"Inherited bi allelic CSFR3 mutations in Severe Congenital neutropenia","volume":"123","author":"Tricot","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2017.04.004_bib101","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1149","article-title":"Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease","volume":"34","author":"Hernandez","year":"2003","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib102","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.10255","article-title":"Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry","volume":"72","author":"Dale","year":"2003","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2017.04.004_bib103","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/INF.0b013e3182814b5a","article-title":"Infectious complications in children with severe congenital, autoimmune or idiopathic neutropenia: a retrospective study from the Italian Neutropenia Registry","volume":"32","author":"Fioredda","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib104","first-page":"45","article-title":"Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group","volume":"90","author":"Donadieu","year":"2005","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib105","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2010.08216.x","article-title":"Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy","volume":"150","author":"Rosenberg","year":"2010","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2017.04.004_bib106","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1182\/blood-2006-02-004275","article-title":"Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey","volume":"109","author":"Germeshausen","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2017.04.004_bib107","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood-2007-03-081216","article-title":"Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia","volume":"110","author":"Link","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib108","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fonc.2013.00089","article-title":"Stochastic hypothesis of transition from inborn neutropenia to AML: interactions of cell population dynamics and population genetics","volume":"3","author":"Kimmel","year":"2013","journal-title":"Front Oncol"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/asheducation-2015.1.1","article-title":"Games of clones the genetic evolution of severe congenital neutropenia Hematology","volume":"2015","author":"Touw","year":"2015","journal-title":"Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1053\/j.seminhematol.2017.04.004_bib110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/shem.2002.31912","article-title":"Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias","volume":"39","author":"Freedman","year":"2002","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib111","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2013-11-538025","article-title":"Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis","volume":"123","author":"Skokowa","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib112","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/70544","article-title":"Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis","volume":"23","author":"Horwitz","year":"1999","journal-title":"Nat Genet"},{"issue":"21","key":"10.1053\/j.seminhematol.2017.04.004_bib113","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1182\/blood-2015-12-685784","article-title":"Two cases of cyclic neutropenia with acquired CSF3R mutations, with 1 developing AML","volume":"127","author":"Klimiankou","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2017.04.004_bib114","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ajh.22242","article-title":"Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica)","volume":"87","author":"Fioredda","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib115","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/bmt.2015.117","article-title":"Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes","volume":"50","author":"Peffault de Latour","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2017.04.004_bib116","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood-2015-02-628859","article-title":"Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation","volume":"126","author":"Fioredda","year":"2015","journal-title":"Blood"},{"issue":"17","key":"10.1053\/j.seminhematol.2017.04.004_bib117","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1182\/blood-2016-07-727891","article-title":"Long-term use of pegfilgrastim in children with severe congenital neutropenia: clinical and pharmacokinetic data","volume":"128","author":"Fioredda","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2017.04.004_bib118","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3324\/haematol.2013.083873","article-title":"Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis","volume":"99","author":"Morishima","year":"2014","journal-title":"Haematologica"},{"issue":"8","key":"10.1053\/j.seminhematol.2017.04.004_bib119","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1073\/pnas.1217039110","article-title":"Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells","volume":"110","author":"Hiramoto","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1053\/j.seminhematol.2017.04.004_bib120","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1172\/JCI80924","article-title":"Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells","volume":"125","author":"Nayak","year":"2015","journal-title":"J Clin Invest"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196317300458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196317300458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:25:48Z","timestamp":1758522348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196317300458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":120,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0037196317300458"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2017.04.004","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2017.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}